We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Response to cladribine in previously treated patients with chronic lymphocytic leukaemia identified by ex vivo assessment of drug sensitivity by DiSC assay.
- Authors
Bosanquet, Andrew G.; Copplestone, J. Adrian; Johnson, Stephen A. N.; Smith, Alastair G.; Povey, Sara J.; Orchard, Jennifer A.; Oscier, David G.; Bosanquet
- Abstract
The ability to identify non-responders to cytotoxic chemotherapy has significant clinical and economic benefits. Differential staining cytotoxicity (DiSC) assays were performed in 34 previously treated patients with chronic lymphocytic leukaemia prior to treatment with cladribine. Of the 28 identified as ex vivo sensitive, 26 achieved a complete (CR) or partial response (PR) (median length of response 1.5 years, median survival 3.37 years) and two had a >70% fall in lymphocytes: six identified as ex vivo resistant failed to respond. The DiSC assay can accurately identify a subgroup of patients resistant to cladribine.
- Subjects
CHRONIC lymphocytic leukemia; LYMPHOCYTES; CELLULAR immunity; DRUG therapy
- Publication
British Journal of Haematology, 1999, Vol 106, Issue 2, p474
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1046/j.1365-2141.1999.01581.x